4don MSN
How a tryptophan-rich allosteric communication network helps activate a major drug target receptor
A multinational research team led by researchers at Institute of Science Tokyo, RIKEN, and the University of Toronto has ...
Morning Overview on MSN
Researchers identify a promising new drug target for tuberculosis
A team of scientists has identified an enzyme called PurF as a new drug target for tuberculosis, offering a fresh line of ...
Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.
Researchers from Imperial and the London School of Hygiene & Tropical Medicine (LSHTM) have discovered a drug target that ...
About Insilico Medicine: Insilico Medicine is a clinical-stage biotechnology company using AI for drug development across cancer, fibrosis, immunity, central nervous system diseases, and aging-related ...
The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors ...
However, a decision taken by the company earlier in 2024 underlined how researchers in sectors like drug discovery see the ...
Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...
Structurally novel neurokinin-1 receptor inhibitors reduce depressive-like behavior and brain inflammation in mice SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ --Researchers report that redesigning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results